Total Payments
$762,639
2024 Payments
$102,401
Companies
25
Transactions
654
Medicare Patients
12,790
Medicare Billing
$2.6M
Payment Breakdown by Category
Other$515,476 (67.6%)
Consulting$150,753 (19.8%)
Travel$81,642 (10.7%)
Food & Beverage$14,643 (1.9%)
Education$87.92 (0.0%)
Gifts$36.64 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $483,682 | 92 | 63.4% |
| Consulting Fee | $150,753 | 65 | 19.8% |
| Travel and Lodging | $81,642 | 202 | 10.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $23,300 | 7 | 3.1% |
| Food and Beverage | $14,643 | 280 | 1.9% |
| Honoraria | $6,050 | 2 | 0.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,444 | 3 | 0.3% |
| Education | $87.92 | 1 | 0.0% |
| Gift | $36.64 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $336,790 | 234 | $0 (2024) |
| Dutch Ophthalmic, USA | $93,280 | 46 | $0 (2024) |
| Allergan, Inc. | $88,125 | 149 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $44,693 | 40 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $44,127 | 31 | $0 (2020) |
| Biogen, Inc. | $30,574 | 13 | $0 (2022) |
| Dutch Ophthalmic Research Center (International) B.V. | $27,064 | 13 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $21,627 | 20 | $0 (2017) |
| AbbVie Inc. | $18,436 | 14 | $0 (2023) |
| Carl Zeiss Meditec, Inc. | $18,157 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $102,401 | 82 | Regeneron Healthcare Solutions, Inc. ($78,045) |
| 2023 | $102,490 | 70 | Regeneron Healthcare Solutions, Inc. ($60,976) |
| 2022 | $102,530 | 59 | Regeneron Healthcare Solutions, Inc. ($35,090) |
| 2021 | $75,734 | 70 | Regeneron Healthcare Solutions, Inc. ($39,574) |
| 2020 | $61,884 | 42 | Regeneron Healthcare Solutions, Inc. ($24,009) |
| 2019 | $136,612 | 125 | Novartis Pharmaceuticals Corporation ($44,085) |
| 2018 | $75,639 | 72 | Regeneron Healthcare Solutions, Inc. ($24,592) |
| 2017 | $105,350 | 134 | Regeneron Healthcare Solutions, Inc. ($43,897) |
All Payment Transactions
654 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,780.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $134.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/21/2024 | Carl Zeiss Meditec USA, Inc. | RESCAN 700 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,240.00 | General |
| Category: Surgical Microscope | ||||||
| 11/20/2024 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $60.17 | General |
| Category: Ophthalmology | ||||||
| 11/16/2024 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Travel and Lodging | In-kind items and services | $1,679.36 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $2.68 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/30/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,580.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $1,481.63 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/19/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $168.89 | General |
| 10/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/15/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $3.78 | General |
| 10/12/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $29.79 | General |
| 10/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $73.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $48.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/11/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $6.06 | General |
| 10/10/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $940.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/09/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $6.56 | General |
| 10/07/2024 | Carl Zeiss Meditec, Inc. | VisuMax (Device), QUATERA 700, Humphrey Field Analyzer (HFA3) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,240.00 | General |
| Category: Surgical Optical Laser | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $500.98 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $334.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/12/2024 | Carl Zeiss Meditec USA, Inc. | CIRRUS HD-OCT (Device), CLARUS | Consulting Fee | Cash or cash equivalent | $4,050.00 | General |
| Category: Optical Tomography | ||||||
| 09/12/2024 | Carl Zeiss Meditec USA, Inc. | CIRRUS HD-OCT (Device), CLARUS | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,240.00 | General |
| Category: Optical Tomography | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 172 | 312 | $472,065 | $71,172 |
| 2022 | 13 | 2,639 | 4,403 | $1.6M | $545,896 |
| 2021 | 15 | 4,166 | 6,789 | $2.2M | $763,387 |
| 2020 | 19 | 5,813 | 9,694 | $3.4M | $1.2M |
Total Patients
12,790
Total Services
21,198
Medicare Billing
$2.6M
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 21 | 88 | $396,000 | $51,873 | 13.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 37 | 53 | $14,045 | $6,774 | 48.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 23 | 41 | $32,250 | $4,660 | 14.5% |
| 92134 | Imaging of retina | Office | 2023 | 65 | 104 | $20,800 | $4,201 | 20.2% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 26 | 26 | $8,970 | $3,664 | 40.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 109 | 432 | $864,000 | $308,075 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 350 | 514 | $97,660 | $49,213 | 50.4% |
| J3590 | Unclassified biologics | Office | 2022 | 16 | 24 | $120,000 | $43,795 | 36.5% |
| 92134 | Imaging of retina | Office | 2022 | 683 | 1,314 | $118,260 | $40,593 | 34.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 296 | 308 | $67,760 | $28,070 | 41.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 137 | 292 | $178,200 | $26,281 | 14.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 185 | 276 | $35,880 | $18,665 | 52.0% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 561 | 907 | $27,210 | $10,894 | 40.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 78 | 92 | $14,260 | $5,710 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $11,600 | $5,335 | 46.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 48 | 48 | $12,720 | $5,300 | 41.7% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 117 | 124 | $5,580 | $2,243 | 40.2% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 19 | 32 | $4,000 | $1,722 | 43.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 159 | 634 | $1.2M | $463,150 | 37.2% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 1,054 | 1,995 | $179,515 | $58,253 | 32.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 590 | 632 | $139,040 | $56,204 | 40.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 341 | 576 | $89,280 | $39,741 | 44.5% |
| 67028 | Injection of drug into eye | Office | 2021 | 204 | 391 | $235,800 | $33,662 | 14.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 284 | 332 | $63,080 | $32,995 | 52.3% |
| 92202 | Extended examination of eye with drawing of optic nerve and surrounding area (macula) | Office | 2021 | 888 | 1,485 | $44,550 | $17,342 | 38.9% |
About Dr. Gaurav Shah, MD
Dr. Gaurav Shah, MD is a Retina Specialist healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1972502383.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gaurav Shah, MD has received a total of $762,639 in payments from pharmaceutical and medical device companies, with $102,401 received in 2024. These payments were reported across 654 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($483,682).
As a Medicare-enrolled provider, Shah has provided services to 12,790 Medicare beneficiaries, totaling 21,198 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location San Francisco, CA
- Active Since 07/18/2005
- Last Updated 08/30/2023
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1972502383
Products in Payments
- EYLEA (Biological) $147,594
- EYLEA HD (Biological) $122,763
- OZURDEX (Drug) $87,945
- EVA Ophthalmic Surgical System (Device) $78,586
- EYLEA AFLIBERCEPT INJECTION (Biological) $68,489
- EVA, combined machine (Device) $41,757
- MACUGEN (Drug) $21,220
- CIRRUS HD-OCT (Device) $19,897
- VISUDYNE (Drug) $14,624
- RETISERT (Drug) $10,022
- STELLARIS (Device) $9,325
- STELLARIS PC (Device) $6,423
- Cimerli (Biological) $6,305
- XIPERE (Drug) $5,251
- RESCAN 700 (Device) $3,240
- VisuMax (Device) $3,240
- FORUM (Device) $2,750
- VITESSE (Device) $2,382
- BEOVU (Drug) $2,302
- STELLARIS ELITE (Device) $1,758
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Retina Specialist Doctors in San Francisco
Malini Pasricha, Md, MD
Retina Specialist — Payments: $12,732
Retina Specialist $12,732
Dr. Robert Kim, Md, MD
Retina Specialist — Payments: $5,432
Retina Specialist $5,432
Andrew Lin, Md, Ms, MD, MS
Retina Specialist — Payments: $1,658
Retina Specialist $1,658
Dr. Georgia Kamboj, Mbbs, Phd, MBBS, PHD
Retina Specialist — Payments: $850.21
Retina Specialist $850.21
Dr. Anita Agarwal, Md, MD
Retina Specialist — Payments: $306.11
Retina Specialist $306.11
Param Bhatter, Md, MD
Retina Specialist
Retina Specialist